7 results
Summary of characteristics of Antianginal Drugs

DRUG CLASS, ADVERSE EFFECTS 
 AND DRUG 
INTERACTIONS 

#Antianginal #Medications #Cardiology
of Antianginal Drugs ... #Medications #Cardiology ... #Pharmacology # ... Management #Therapy ... #Table #Overview
Summary table of mechanism of action, side effect and contraindications of commonly used drugs for tuberculosis.
commonly used drugs ... for tuberculosis ... #pharmacology #medications ... #table #management ... #overview #tuberculosis
Warfarin color-coded tablets, initial dosing and INR targets

#pharmacology #overview #review #medications #drugs #cardiology #warfarin #management
INR targets #pharmacology ... #overview #review ... #medications #drugs ... #cardiology #warfarin ... #management
IDSA - Clinical Strategy to Build an Individualized Treatment Regimen for Multi-Drug Resistant Tuberculosis (MDR-TB)
 •
Resistant Tuberculosis ... (MDR-TB) • Build ... MultiDrugResistant #Tuberculosis ... #MDRTB #management ... antimicrobials #regimens #pharmacology
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... million new M. tuberculosis ... (MDR-TB) accounts ... inhibitors • Injection drug ... #Management #Treatment
Tuberculosis Overview

10 million new M. tuberculosis infections/year
Facultative intracellular rod-shaped bacteria
Multidrug-resistant tuberculosis (MDR-TB) accounts for 4.6% of
Tuberculosis Overview ... million new M. tuberculosis ... (MDR-TB) accounts ... inhibitors • Injection drug ... #Management #Treatment
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
Mycobacterium Tuberculosis ... drugs after consultation ... Mycobacterium #Tuberculosis ... #Treatment #management ... infections #HIVAIDS #pharmacology